Assuntos
COVID-19 , Miocardite , Vacinas contra COVID-19 , Humanos , SARS-CoV-2 , Vacinas Sintéticas , Vacinas de mRNARESUMO
The recent development of endothelin-1 (ET-1) antagonists and their potential use in the treatment of human disease raises questions as to the role of ET-1 in the pathophysiology of such cardiovascular ailments as hypertension, heart failure, renal failure and atherosclerosis. It is still unclear, for example, whether activation of an endogenous ET-1 system is itself the primary cause of any of these ailments. In that context, the phenotypic manifestations of chronic ET-1 overproduction may provide clues about the tissues and systems affected by ET-1. We therefore established two lines of transgenic mice overexpressing the ET-1 gene under the direction of its own promoter. These mice exhibited low body weight, diminished fur density and two- to fourfold increases in the ET-1 levels measured in plasma, heart, kidney and aorta. There were no apparent histological abnormalities in the visceral organs of young (8 weeks old) transgenic mice, nor was their blood pressure elevated. In aged (12 months old) transgenic mice, however, renal manifestations, including prominent interstitial fibrosis, renal cysts, glomerulosclerosis and narrowing of arterioles, were detected. These pathological changes were accompanied by decreased creatinine clearance, elevated urinary protein excretion and salt-dependent hypertension. It thus appears that mild, chronic overproduction of ET-1 does not primarily cause hypertension but triggers damaging changes in the kidney which lead to the susceptibility to salt-induced hypertension.
Assuntos
Envelhecimento/genética , Endotelina-1/biossíntese , Hipertensão/genética , Hipertensão/fisiopatologia , Nefropatias/genética , Nefropatias/fisiopatologia , Cloreto de Sódio na Dieta/metabolismo , Animais , Pressão Sanguínea/genética , Pressão Sanguínea/fisiologia , Creatinina/sangue , Creatinina/metabolismo , Endotelina-1/sangue , Endotelina-1/genética , Coração/fisiopatologia , Frequência Cardíaca/genética , Frequência Cardíaca/fisiologia , Hipertensão/sangue , Rim/irrigação sanguínea , Rim/fisiopatologia , Rim/ultraestrutura , Nefropatias/sangue , Masculino , Taxa de Depuração Metabólica/genética , Taxa de Depuração Metabólica/efeitos da radiação , Camundongos , Camundongos Transgênicos , Microinjeções/métodos , Microscopia Eletrônica de Varredura , Óvulo/química , Óvulo/crescimento & desenvolvimento , Óvulo/metabolismo , Fenótipo , Transgenes/genéticaRESUMO
BACKGROUND AND STUDY AIMS: Although rectal varices constitute an important cause of lower digestive tract bleeding in patients with portal hypertension, the etiology and pathology of rectal varices remains controversial, and adequate treatment for rectal varices has yet to be established. In this study, we evaluated rectal varices to identify any common characteristics of varices which are susceptible to hemorrhage. PATIENTS AND METHODS: The patients included 40 individuals with rectal varices among 425 patients with portal hypertension who had been treated in our institution. We retrospectively examined patient data regarding underlying hepatic diseases, hepatic function and endoscopic findings with regard to varices. RESULTS: Bleeding from rectal varices occurred in 15 of the 40 patients. Although the prevalence of hemorrhage tended to increase with exacerbation of hepatic dysfunction, no significant differences were found. Similarly, although the incidence of hemorrhage tended to be somewhat higher in patients who had undergone any treatment for complicated esophageal varices than in patients who had not, no significant difference was found. The prevalence of hemorrhage from rectal varices significantly increased in rectal varices of more advanced form, and the prevalence was significantly higher in patients with positive "red color" sign. CONCLUSIONS: The prevalence of hemorrhage from rectal varices was significantly higher in patients with rectal varices of advanced form and/or with a positive "red color" sign.
Assuntos
Hemorragia Gastrointestinal/etiologia , Reto/irrigação sanguínea , Varizes/etiologia , Idoso , Idoso de 80 Anos ou mais , Cor , Feminino , Humanos , Hipertensão Portal/complicações , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Varizes/complicaçõesAssuntos
Infecção Hospitalar/epidemiologia , Unidades Hospitalares , Unidades de Terapia Intensiva Neonatal , Berçários Hospitalares , Infecções Estafilocócicas/epidemiologia , Staphylococcus aureus/genética , Antibacterianos/farmacologia , Criança , Pré-Escolar , DNA Bacteriano/análise , Surtos de Doenças , Eletroforese em Gel de Campo Pulsado , Humanos , Lactente , Recém-Nascido , Resistência a Meticilina , Testes de Sensibilidade Microbiana , Epidemiologia Molecular , Pediatria , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/classificação , Staphylococcus aureus/efeitos dos fármacosRESUMO
Amiodarone is a highly effective antiarrhythmic agent for the prevention of life-threatening arrhythmias. Two cases are described of patients who developed bronchial asthma after treatment with amiodarone. The bronchial asthma resolved after the dose of amiodarone was decreased in both patients. To our knowledge, an association between amiodarone and severe bronchial asthma has previously been reported only once in the medical literature. Physicians should note that amiodarone may cause bronchospasm in susceptible patients.
Assuntos
Amiodarona/efeitos adversos , Antiarrítmicos/efeitos adversos , Asma/induzido quimicamente , Idoso , Feminino , Humanos , MasculinoRESUMO
Cardiac involvement is an important prognostic factor in sarcoidosis, but reliable indicators of mortality risk in cardiac sarcoidosis are unstudied in a large number of patients. To determine the significant predictors of mortality and to assess the efficacy of corticosteroids, we analyzed clinical findings, treatment, and prognosis in 95 Japanese patients with cardiac sarcoidosis. Twenty of these 95 patients had cardiac sarcoidosis proven by autopsy; none of these patients had received corticosteroids. We assessed 12 clinical variables as possible predictors of mortality by Cox proportional hazards model in 75 steroid-treated patients. During the mean follow-up of 68 months, 29 patients (73%) died of congestive heart failure and 11 (27%) experienced sudden death. Kaplan-Meier survival curves showed 5-year survival rates of 75% in the steroid-treated patients and of 89% in patients with a left ventricular ejection fraction > or = 50%, whereas there was only 10% 5-year survival rate in autopsy subjects. There was no significant difference in survival curves of patients treated with a high initial dose (> 30 mg) and a low initial dose (> or = 30 mg) of prednisone. Multivariate analysis identified New York Heart Association functional class (hazard ratio 7.72 per class I increase, p = 0.0008), left ventricular end-diastolic diameter (hazard ratio 2.60/10 mm increase, p = 0.02), and sustained ventricular tachycardia (hazard ratio 7.20, p = 0.03) as independent predictors of mortality. In conclusion, the severity of heart failure was one of the most significant independent predictors of mortality for cardiac sarcoidosis. Starting corticosteroids before the occurrence of systolic dysfunction resulted in an excellent clinical outcome. A high initial dose of prednisone may not be essential for treatment of cardiac sarcoidosis.
Assuntos
Cardiomiopatias/tratamento farmacológico , Cardiomiopatias/mortalidade , Glucocorticoides/uso terapêutico , Prednisona/uso terapêutico , Sarcoidose/tratamento farmacológico , Sarcoidose/mortalidade , Idoso , Feminino , Glucocorticoides/administração & dosagem , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Prognóstico , Modelos de Riscos Proporcionais , Análise de SobrevidaRESUMO
alpha-Calcitonin gene-related peptide (alphaCGRP) is a pleiotropic neuropeptide implicated in a variety of physiological processes. To better understand the biological functions of alphaCGRP, we developed an alphaCGRP-null mouse model using a gene targeting approach. Recordings of mean arterial pressure (MAP) and heart rate (HR) showed that basal MAP and HR were significantly higher in both anesthetized and conscious, unrestrained alphaCGRP-null mice than in corresponding wild-type mice. The elevated MAP in alphaCGRP-null mice was shown to be the result of elevated peripheral vascular resistance by alpha-adrenergic blockade with prazosin and by transthoracic echocardiogram, which revealed no significant differences between alphaCGRP-null and wild-type mice in the stroke volume, fractional shortening, and ejection fraction. Moreover, evaluation of autonomic nervous activity by measuring HR after pretreatment of atropine and/or atenolol and by analyzing arterial baroreceptor reflexes showed sympathetic nervous activity to be significantly elevated in alphaCGRP-null mice; elevated levels of urinary catecholamine metabolites and decreased HR variability in mutant mice were also consistent with that finding. These findings suggest that alphaCGRP contributes to the regulation of cardiovascular function through inhibitory modulation of sympathetic nervous activity.
Assuntos
Peptídeo Relacionado com Gene de Calcitonina/genética , Peptídeo Relacionado com Gene de Calcitonina/fisiologia , Sistema Nervoso Simpático/fisiologia , Antagonistas Adrenérgicos alfa/farmacologia , Antagonistas Adrenérgicos beta/farmacologia , Animais , Atenolol/farmacologia , Atropina/farmacologia , Barorreflexo , Pressão Sanguínea/efeitos dos fármacos , Marcação de Genes , Frequência Cardíaca/efeitos dos fármacos , Camundongos , Camundongos Knockout , Antagonistas Muscarínicos/farmacologia , Prazosina/farmacologia , Resistência VascularRESUMO
BACKGROUND: Adrenomedullin (AM) is a vasodilating peptide involved in the regulation of circulatory homeostasis and in the pathophysiology of certain cardiovascular diseases. Levels of AM are markedly increased in the fetoplacental circulation during pregnancy, although its function there remains unknown. To clarify the physiological functions of AM, we chose a gene-targeting strategy in mice. METHODS AND RESULTS: Targeted null mutation of the AM gene is lethal in utero: the mortality rate among AM(-/-) embryos was >80% at E13.5. The most apparent abnormality in surviving AM(-/-) embryos at E13.5 to E14.0 was severe hemorrhage, readily observable under the skin and in visceral organs. Hemorrhage was not detectable at E12.5 to E13.0, although the yolk sac lacked well-developed vessels. Electron microscopic examination showed endothelial cells to be partially detached from the basement structure at E12.5 in vitelline vessels and hepatic capillaries, which allowed efflux of protoerythrocytes through the disrupted barrier. The basement membrane was not clearly recognizable in the aorta and cervical artery, and the endothelial cells stood out from the wall of the lumen, only partially adhering to the basement structure. AM(+/-) mice survived to adulthood but exhibited elevated blood pressures with diminished nitric oxide production. CONCLUSIONS: AM is indispensable for the vascular morphogenesis during embryonic development and for postnatal regulation of blood pressure by stimulating nitric oxide production.
Assuntos
Vasos Sanguíneos/anormalidades , Anormalidades Cardiovasculares/patologia , Hipertensão/patologia , Peptídeos/deficiência , Adrenomedulina , Animais , Vasos Sanguíneos/patologia , Vasos Sanguíneos/ultraestrutura , Perda do Embrião/etiologia , Perda do Embrião/patologia , Endotélio Vascular/embriologia , Endotélio Vascular/patologia , Endotélio Vascular/ultraestrutura , Feminino , Marcação de Genes , Genes Letais , Genótipo , Hemodinâmica/genética , Hemorragia/embriologia , Hemorragia/genética , Hemorragia/patologia , Heterozigoto , Homozigoto , Hipertensão/genética , Hipertensão/fisiopatologia , Endogamia , Bombas de Infusão , Injeções Subcutâneas , Masculino , Camundongos , Camundongos Knockout , Óxido Nítrico/metabolismo , Peptídeos/administração & dosagem , Peptídeos/genética , Fenótipo , Proteínas Recombinantes/administração & dosagem , Membrana Vitelina/irrigação sanguínea , Membrana Vitelina/embriologia , Membrana Vitelina/patologiaAssuntos
Infecção Hospitalar/microbiologia , Meticilina/farmacologia , Penicilinas/farmacologia , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/efeitos dos fármacos , Análise por Conglomerados , DNA Bacteriano/genética , Eletroforese em Gel de Campo Pulsado , Humanos , Resistência a Meticilina , Infecções Estafilocócicas/complicações , Infecções Estafilocócicas/transmissão , Staphylococcus aureus/genética , Staphylococcus aureus/isolamento & purificação , Tuberculose/complicaçõesAssuntos
Infecção Hospitalar/microbiologia , Resistência a Meticilina , Meticilina/farmacologia , Penicilinas/farmacologia , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/genética , Infecção Hospitalar/transmissão , DNA Bacteriano/análise , Eletroforese em Gel de Campo Pulsado , Humanos , Infecções Estafilocócicas/epidemiologia , Infecções Estafilocócicas/transmissão , Staphylococcus aureus/efeitos dos fármacosRESUMO
It remains to be defined whether molecular variants of the genes underlying Mendelian forms of hypertension play some etiological role in essential hypertension. To pursue this issue, we focused on the following three genes: the epithelial sodium channel (ENaC), 11beta-hydroxysteroid dehydrogenase type 2, and mineralocorticoid receptor genes. Five sequence variations of these genes, which were either previously reported to show significant association with hypertension or identified as "mild" molecular variants, were chosen for our study. Each variation was screened in 247 severe hypertensive patients with early onset (<45 years) and any detectable variations were subsequently characterized in 291 older normotensive subjects (>60 years) for the case-control comparison. We also investigated the significance of association between the tested variants and biochemical parameters reflecting sodium-water homeostasis, such as plasma aldosterone concentration (PAC) and renin activity (PRA). Only the T663A variant (alpha-subunit of ENaC) turned out to be polymorphic in the Japanese population. In disagreement with positive associations previously reported in white and black subjects, we observed no significant association between T663A and hypertension, while allele frequencies of A663 were higher in Japanese (58-64%) compared with a reported prevalence of 29% in whites and 15% in blacks. T663A showed a borderline association (p=0.02) with the PAC/PRA ratio but not with PAC or PRA in the multivariate analysis. Our data did not support the association between Mendelian disease gene variants and essential hypertension in the Japanese. However, the present study did not definitively resolve this issue and further investigation is certainly warranted.
Assuntos
Hipertensão/genética , Polimorfismo de Nucleotídeo Único , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2 , Idoso , Canais Epiteliais de Sódio , Feminino , Genótipo , Humanos , Hidroxiesteroide Desidrogenases/genética , Japão , Masculino , Pessoa de Meia-Idade , Receptores de Mineralocorticoides/genética , Canais de Sódio/genéticaRESUMO
Growth hormone (GH) has been reported to be useful to treat heart failure. To elucidate whether GH has direct beneficial effects on the heart, we examined effects of GH on oxidative stress-induced apoptosis in cardiac myocytes. TUNEL staining and DNA ladder analysis revealed that hydrogen peroxide (H2O2)-induced apoptosis of cardiomyocytes was significantly suppressed by the pretreatment with GH. GH strongly activated extracellular signal-regulated kinases (ERKs) in cardiac myocytes and the cardioprotective effect of GH was abolished by inhibition of ERKs. Overexpression of dominant negative mutant Ras suppressed GH-stimulated ERK activation. Overexpression of Csk that inactivates Src family tyrosine kinases also inhibited ERK activation evoked by GH. A broad-spectrum inhibitor of protein tyrosine kinases (PTKs), genistein, strongly suppressed GH-induced ERK activation and the cardioprotective effect of GH against apoptotic cell death. GH induced tyrosine phosphorylation of EGF receptor and JAK2 in cardiac myocytes, and an EGF receptor inhibitor tyrphostin AG1478 and a JAK2 inhibitor tyrphostin B42 completely inhibited GH-induced ERK activation. Tyrphostin B42 also suppressed the phosphorylation of EGF receptor stimulated by GH. These findings suggest that GH has a direct protective effect on cardiac myocytes against apoptosis and that the effect of GH is attributed at least in part to the activation of ERKs through Ras and PTKs including JAK2, Src, and EGF receptor tyrosine kinase.
Assuntos
Apoptose/fisiologia , Coração/efeitos dos fármacos , Hormônio do Crescimento Humano/farmacologia , Miocárdio/metabolismo , Proteínas Proto-Oncogênicas , Transdução de Sinais/fisiologia , Animais , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Flavonoides/farmacologia , Genisteína/farmacologia , Peróxido de Hidrogênio/farmacologia , Marcação In Situ das Extremidades Cortadas , Janus Quinase 2 , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Miocárdio/citologia , Naftalenos/farmacologia , Oxidantes/farmacologia , Estresse Oxidativo , Proteínas Tirosina Quinases/metabolismo , Proteínas Proto-Oncogênicas c-raf/metabolismo , Ratos , Ratos Wistar , Tirfostinas/farmacologia , Proteínas ras/metabolismo , Quinases da Família src/metabolismoRESUMO
Increasing evidence has suggested that mitogen-activated protein kinases (MAPKs) play important roles in the development of cardiac hypertrophy. We and others have reported that the activity of MAPKs is tightly regulated by angiotensin II (Ang II) in cardiac myocytes. In the present study, we determined the molecular mechanism of Ang II-induced inactivation of MAPKs in rat neonatal cardiac myocytes. Ang II increased MAPK phosphatase 1 (MKP-1) gene expressions within 10 min. Levels of MKP-1 transcripts peaked at 30 min and gradually decreased thereafter. The increase in MKP-1 mRNA levels was Ang II-concentration dependent. An Ang II type 1 receptor (AT1)-specific antagonist, CV-11974, completely suppressed the Ang II-induced increase in MKP-1 gene expression, while a type 2 receptor (AT2)-specific antagonist, PD-123319, had no significant effects. Induction of MKP-1 gene expressions by Ang II was inhibited by pretreatment with an intracellular Ca2+ chelator, BAPTA-AM, or with the protein kinase C inhibitors, H-7 and Calphostin C. Phorbol ester and Ca2+ ionophore both significantly increased MKP-1 mRNA levels and showed synergistic action. Overexpression of MKP-1 cDNA blocked the Ang II-induced increase in expressions of immediate early response genes. In addition, Ang II-induced MAPK activation was significantly inhibited by pretreatment with CV-11974, but significantly enhanced by pretreatment with PD-123319. Addition of the AT2 agonist, CGP42112A, reduced basal MAPK activities, and pretreatment with PD-123319 abolished MAPK inactivation by CGP42112A. In conclusion, these observations suggest that Ang II negatively regulates MAPKs through AT1 receptors by increasing MKP-1 mRNA levels and through AT2 receptors by unknown mechanisms.
Assuntos
Angiotensina II/farmacologia , Proteínas de Ciclo Celular , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Miocárdio/enzimologia , Fosfoproteínas Fosfatases , Animais , Cálcio/fisiologia , Células Cultivadas , Fosfatase 1 de Especificidade Dupla , Ativação Enzimática/fisiologia , Expressão Gênica/efeitos dos fármacos , Expressão Gênica/fisiologia , Proteínas Imediatamente Precoces/genética , Miocárdio/citologia , Proteína Quinase C/fisiologia , Proteína Fosfatase 1 , Proteína Tirosina Fosfatase não Receptora Tipo 1 , Proteínas Tirosina Fosfatases/genética , Ratos , Ratos Wistar , Receptor Tipo 1 de Angiotensina , Receptor Tipo 2 de Angiotensina , Receptores de Angiotensina/fisiologia , Transcrição Gênica/efeitos dos fármacosRESUMO
Intravenous administration of isoproterenol restored the ST-segment configuration to nearly normal in the right precordial leads and completely prevented spontaneous VF attacks in a patient with Brugada syndrome. The formation of a Brugada-type ECG has been attributed to the transmural dispersion of repolarization of the right ventricular epicardium and related to modulation of the autonomic nervous system. Our case may provide clues to the pathophysiological mechanism of this syndrome.
Assuntos
Bloqueio de Ramo/complicações , Cardiotônicos/uso terapêutico , Isoproterenol/uso terapêutico , Fibrilação Ventricular/prevenção & controle , Adulto , Morte Súbita Cardíaca/prevenção & controle , Eletrocardiografia , Humanos , Infusões Intravenosas , Masculino , Recidiva , Síndrome , Fibrilação Ventricular/etiologiaRESUMO
To elucidate pathophysiological roles of heme oxygenase (HO)-1 in regulation of vascular tone in vivo, we have developed and characterized transgenic (Tg) mice that overexpress HO-1 site specifically in vascular smooth muscle cells (VSMCs). The Tg mice were generated by use of human HO-1 cDNA under the control of SM22-alpha promoter. The HO-1 gene overexpression was demonstrated by Northern blot analysis and coincided with increases in the protein expression in VSMCs and total HO activities. Tg mice exhibited a significant increase in arterial pressure at various ages and displayed impaired nitrovasodilatory responses in isolated aortic segments versus nontransgenic littermates while enhancing their nitric oxide (NO) production. The pressure of Tg mice was unchanged by systemic administration of either N(omega)-nitro-L-arginine or SNP. Furthermore, the isolated aorta in these mice exhibited lesser extents of NO-elicited cGMP elevation via soluble guanylate cyclase (sGC), while exhibiting no notable downregulation of sGC expression. Such impairment of the NO-elicited cGMP increase was restored significantly by tin protoporphyrin IX, an HO inhibitor. On the other hand, 3-(5'-hydroxymethyl-2' furyl)-1-benzyl-indazol (YC-1), an NO-independent activator of sGC, increased cGMP and relaxed aortas from Tg mice to levels comparable with those from nontransgenic mice, which indicates that contents of functionally intact sGC are unlikely to differ between the two systems. These findings suggest that site-specific overexpression of HO-1 in VSMCs suppresses vasodilatory response to NO and thereby leads to an elevation of arterial pressure.
Assuntos
Pressão Sanguínea , Heme Oxigenase (Desciclizante)/genética , Músculo Liso Vascular/enzimologia , Óxido Nítrico/antagonistas & inibidores , Vasodilatação , Animais , Aorta/efeitos dos fármacos , Aorta/metabolismo , Pressão Sanguínea/efeitos dos fármacos , Técnicas de Cultura , GMP Cíclico/metabolismo , Inibidores Enzimáticos/farmacologia , Guanilato Ciclase/metabolismo , Heme Oxigenase (Desciclizante)/metabolismo , Heme Oxigenase-1 , Hipertensão/metabolismo , Hipertensão/fisiopatologia , Rim/metabolismo , Proteínas de Membrana , Metaloporfirinas/farmacologia , Camundongos , Camundongos Transgênicos , Óxido Nítrico/biossíntese , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Óxido Nítrico Sintase Tipo III , Nitroarginina/farmacologia , Nitroprussiato/farmacologia , Protoporfirinas/farmacologia , Vasodilatação/efeitos dos fármacosRESUMO
The discovery of the natriuretic peptide family was a breakthrough in modern cardiovascular physiology as it provided a direct link between the heart and the kidneys in the regulation of natriuresis. Along with vasopressin and the renin-angiotensin-aldosterone system, the natriuretic peptides comprise the key peptides on which our present understanding of neuroendocrine regulation of the cardiovascular system is based. Three natriuretic peptides have been identified; the A-type, B-type and C-type natriuretic peptides. The former two, the A- and B-type natriuretic peptides, function mainly in the cardiovascular system and comprise the cardiac natriuretic peptides. Together with our increased understanding of the neurohormonal regulation of the cardiovascular system in recent years, the discovery of the natriuretic peptide family was important in the establishment of the new field of cardiovascular endocrinology.
Assuntos
Fenômenos Fisiológicos Cardiovasculares , Natriurese/fisiologia , Peptídeos/fisiologia , Animais , Fator Natriurético Atrial/fisiologia , Modelos Animais de Doenças , Humanos , Peptídeo Natriurético Encefálico/fisiologia , Peptídeo Natriurético Tipo C/fisiologiaRESUMO
OBJECTIVES: We examined whether measurement of the plasma BNP concentrations might be useful for the early diagnosis of the existence and severity of disease in patients with heart disease in daily clinical practice. METHODS AND RESULTS: The plasma BNP and ANP concentrations in 415 patients with heart disease and hypertension and 65 control subjects were measured. Patients with heart disease had higher plasma BNP and ANP concentrations than did those with hypertension or control subjects. Among the etiology of cardiac diseases, specifically dilated cardiomyopathy and hypertrophic cardiomyopathy, was associated with the highest plasma BNP concentrations, whereas dilated cardiomyopathy was associated with the highest plasma ANP concentrations. Plasma BNP concentrations showed an increase as the severity of the heart disease, as graded according to the NYHA classification of cardiac function, increased. In both patients with heart disease and hypertension, the plasma BNP values were higher in those who had abnormalities in their echocardiogram and electrocardiogram as compared to those without any abnormalities. The plasma BNP levels also showed a significant correlation with left ventricular wall thickness and left ventricular mass. On the other hand, the plasma ANP levels showed significant correlations with left ventricular dimension. Receiver operative characteristic analysis revealed that plasma BNP levels showed substantially high sensitivity and specificity to detect the existence of heart diseases. CONCLUSION: Measurements of the plasma BNP concentrations is useful to detect the existence of the diseases, and abnormalities of left ventricular function and hypertrophy in patients with heart disease in daily clinical practice.